AI assistant
Sending…
Evogene Ltd. — Board/Management Information 2019
Mar 14, 2019
6785_rns_2019-03-14_99660da3-3ac9-4c1b-9240-ea0c613bb7b4.htm
Board/Management Information
Open in viewerOpens in your device viewer
_________ false
| ����� ��"� | 2 381 |
| EVOGENE LTD | |
| Corporation no: 512838723 | 11441 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C003 ( Public ) | Reported via MAGNA: | 14/03/2019 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2019-02-022246 | Time of broadcast: 11:35 11:34:20 |
Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
Please note that in the case of delayed publication of report, no changes will be allowed after the form is submitted.
| Delay the publication of a report | 14/03/2019 | 13:01 |
1. The delay of the report can be done up to 72 hours maximum from the date of filling out the form.2. Attention that in accordance with the provisions of the law, the reporting date must be simultaneous with the report in the foreign exchange.
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
| Attached hereto is a report on | AgPlenus - Evogene�s Ag-Chemicals Subsidiary - Announces the Nomination of Three Industry Leaders from the Field of Crop Protection to its Board of Directors |
PR_AgPlenus_BoD__FINAL_isa.pdf
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| - - - | |
| Stock Exchange/Market: -1 | Date of revision of form structure: 19/02/2019 |
| Address: Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121 , Tel: 08-9311900 , Fax: 08-9466724 | |
| E-mail address: [email protected] Company site: www.evogene.com | |
| Previous names of reporting entity: | |
| Name of the Signatory: Bartov Pinto Amitai Position of Signatory in the reporting corporation: Attorney/Legal Counsel Name of Employer Company: | |
| Address: Gad Feinstein 13 , Rehovot 7612002 Telephone: 08-9311962 Facsimile: 08-9466724 E-mail: [email protected] 1 | |
More from Evogene Ltd.
Report Publication Announcement
2026
May 20
Share Issue/Capital Change
2026
May 20
Earnings Release
2026
May 20
Report Publication Announcement
2026
May 20
Prospectus
2026
May 20
Foreign Filer Report
2026
May 20
Report Publication Announcement
2026
May 18
Regulatory Filings
2026
May 18
Foreign Filer Report
2026
May 18
Report Publication Announcement
2026
May 12